Dr. Calais on the Role of PSMA-PET Imaging in mCRPC
March 10th 2023
Jeremie Calais, MD, MSc, discusses the role of prostate-specific membrane antigen-PET imaging in metastatic-castrate resistant prostate cancer, and touches on the importance of integrating PSMA-PET imaging into community settings for clinical practice.